Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
23 Sep 2024 |
TM01 |
Termination of appointment of Thomas Ian Whittle as a director on 20 September 2024
|
|
|
16 Aug 2024 |
CS01 |
Confirmation statement made on 16 August 2024 with no updates
|
|
|
05 Aug 2024 |
AA |
Audit exemption subsidiary accounts made up to 31 December 2023
|
|
|
05 Aug 2024 |
PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 31/12/23
|
|
|
05 Aug 2024 |
AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 31/12/23
|
|
|
05 Aug 2024 |
GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 31/12/23
|
|
|
31 May 2024 |
CS01 |
Confirmation statement made on 24 May 2024 with no updates
|
|
|
31 May 2024 |
PSC05 |
Change of details for Haleon Uk Services Limited as a person with significant control on 31 May 2024
|
|
|
07 Nov 2023 |
PSC05 |
Change of details for Haleon Uk Services Limited as a person with significant control on 18 July 2022
|
|
|
30 Jun 2023 |
AA |
Full accounts made up to 31 December 2022
|
|
|
16 Jun 2023 |
CERTNM |
Company name changed gsk canada holding company LIMITED\certificate issued on 16/06/23
-
NM01 ‐
Change of name by resolution
-
RES15 ‐
Change company name resolution on 2023-06-06
|
|
|
05 Jun 2023 |
PSC05 |
Change of details for Haleon Uk Services Limited as a person with significant control on 18 July 2022
|
|
|
05 Jun 2023 |
CH02 |
Director's details changed for Haleon Uk Corporate Director Limited on 18 July 2022
|
|
|
05 Jun 2023 |
CH02 |
Director's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022
|
|
|
25 May 2023 |
CS01 |
Confirmation statement made on 24 May 2023 with updates
|
|
|
17 May 2023 |
CH02 |
Director's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023
|
|
|
17 May 2023 |
CH02 |
Director's details changed for Gsk Consumer Healthcare Holdings No.4 Limited on 31 March 2023
|
|
|
25 Nov 2022 |
PSC05 |
Change of details for Glaxosmithkline Consumer Healthcare (Overseas) Limited as a person with significant control on 18 November 2022
|
|
|
03 Oct 2022 |
AA |
Full accounts made up to 31 December 2021
|
|
|
15 Aug 2022 |
CH01 |
Director's details changed for Mr Lee Di Pietro on 7 July 2022
|
|
|
18 Jul 2022 |
AD01 |
Registered office address changed from 980 Great West Road Brentford TW8 9GS England to Building 5, First Floor the Heights Weybridge Surrey KT13 0NY on 18 July 2022
|
|
|
24 May 2022 |
CS01 |
Confirmation statement made on 24 May 2022 with no updates
|
|
|
08 Apr 2022 |
SH19 |
Statement of capital on 8 April 2022
|
|
|
08 Apr 2022 |
SH20 |
Statement by Directors
|
|
|
08 Apr 2022 |
CAP-SS |
Solvency Statement dated 06/02/22
|
|